High glucose inhibits osteogenic differentiation and proliferation of MC3T3E1 cells by regulating P2X7.
Mol Med Rep
; 20(6): 5084-5090, 2019 Dec.
Article
en En
| MEDLINE
| ID: mdl-31702818
ABSTRACT
Diabetes mellitus adversely affects human bones and increases the risk of developing osteoporosis. In the present study, treatment with 30 mmol/l glucose was used to establish a high glucose (HG) cell model in vitro. Plasmids were used to overexpress the P2X purinoceptor 7 (P2X7) gene. Brilliant blue G and (4benzoylbenzoyl)ATP were used as a P2X7 antagonist and agonist, respectively. Proliferation of osteogenic MC3T3E1 cells and alkaline phosphatase (ALP) activity were determined using MTT and colorimetric assays, respectively. Alizarin Red S was used to assess calcification of MC3T3E1 cells. Western blotting and reverse transcriptionquantitative PCR were performed to determine protein and mRNA expression levels. The results demonstrated that HG inhibited MC3T3E1 cell proliferation and P2X7 expression, reduced calcification, and downregulated the expression levels of ALP and osteocalcin (Ocn) in MC3T3E1 cells. Overexpression of P2X7 in HG conditions increased calcification and proliferation, and upregulated the levels of ALP and Ocn in MC3T3E1 cells. Inhibition of P2X7 downregulated the expressions of ALP and Ocn in MC3T3E1 cells under HG conditions. Therefore, the present results indicated that HG caused damage to osteogenic MC3T3E1 cells. Thus, P2X7 may be a regulatory factor that may be used to counteract the effects of HG on osteogenesis.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Osteogénesis
/
Diferenciación Celular
/
Proliferación Celular
/
Receptores Purinérgicos P2X7
/
Agonistas del Receptor Purinérgico P2X
/
Glucosa
Tipo de estudio:
Prognostic_studies
Límite:
Animals
/
Humans
Idioma:
En
Revista:
Mol Med Rep
Año:
2019
Tipo del documento:
Article